Back to Search
Start Over
TNFRII polymorphism is associated with response to TNF blockers in rheumatoid arthritis patients seronegative for ACPA
- Source :
- Joint Bone Spine, Joint Bone Spine, Elsevier Masson, 2014, 81 (4), pp.370-372. ⟨10.1016/j.jbspin.2013.12.005⟩
- Publication Year :
- 2014
- Publisher :
- HAL CCSD, 2014.
-
Abstract
- Joint Bone Spine - In Press.Proof corrected by the author Available online since jeudi 23 janvier 2014
- Subjects :
- Adult
Male
[SDV]Life Sciences [q-bio]
Peptides, Cyclic
Arthritis, Rheumatoid
03 medical and health sciences
Young Adult
0302 clinical medicine
Rheumatology
Predictive Value of Tests
SNP LTA + 720
medicine
Humans
Receptors, Tumor Necrosis Factor, Type II
Anti-citrullinated peptide antibodies (ACPA)
ComputingMilieux_MISCELLANEOUS
030304 developmental biology
Aged
030203 arthritis & rheumatology
Aged, 80 and over
0303 health sciences
Polymorphism, Genetic
Genetic polymorphism
business.industry
Tumor Necrosis Factor-alpha
Joint bone
Middle Aged
medicine.disease
3. Good health
SNP TNFRII-codon 196
Rheumatoid arthritis
Antirheumatic Agents
Immunology
Tumor necrosis factor alpha
TNF response
business
SNP IL10-1087
Biomarkers
Subjects
Details
- Language :
- English
- ISSN :
- 1297319X
- Database :
- OpenAIRE
- Journal :
- Joint Bone Spine, Joint Bone Spine, Elsevier Masson, 2014, 81 (4), pp.370-372. ⟨10.1016/j.jbspin.2013.12.005⟩
- Accession number :
- edsair.doi.dedup.....20b7f36e85b9e3808baedf6ce5ecf228
- Full Text :
- https://doi.org/10.1016/j.jbspin.2013.12.005⟩